FMED ETF (Fidelity Disruptive Medicine ETF) is managed by Fidelity Investments (US) with $46.4M in net assets. FMED expense ratio is 0.50%, holding 74 positions across sectors including Health Care, Other, Financials. Inception date: 2023-02-13.

FMED performance shows a YTD return of 5.52%. The 1-year return is 19.03%.

FMED top holdings include Bought INR Sold USD 20251017 (8.6%), Fidelity Securities Lending Cash Central Fund (8.6%), Danaher Corp. (3.8%), Intuitive Surg (3.6%), Ucb Sa (3.4%). View all FMED holdings, sector breakdown, or dividend history.

FMED can be compared against other funds using the overlap calculator or side-by-side comparison tool. FMED alternatives are available via the screener, along with tax-loss harvesting opportunities.